433 related articles for article (PubMed ID: 12693859)
1. Natural influenza A virus infection of mice elicits strong antibody response to HA2 glycopolypeptide.
Kostolanský F; Mucha V; Slováková R; Varecková E
Acta Virol; 2002; 46(4):229-36. PubMed ID: 12693859
[TBL] [Abstract][Full Text] [Related]
2. Differences in antibody responses of mice to intranasal or intraperitoneal immunization with influenza A virus and vaccination with subunit influenza vaccine.
Fislová T; Sládková T; Gocník M; Mucha V; Varecková E; Kostolanský F
Acta Virol; 2005; 49(4):243-50. PubMed ID: 16402681
[TBL] [Abstract][Full Text] [Related]
3. A protective immune response in mice to viral components other than hemagglutinin in a live influenza A virus vaccine model.
Horimoto T; Takada A; Iwatsuki-Horimoto K; Kawaoka Y
Vaccine; 2004 Jun; 22(17-18):2244-7. PubMed ID: 15149783
[TBL] [Abstract][Full Text] [Related]
4. Antibodies induced by the HA2 glycopolypeptide of influenza virus haemagglutinin improve recovery from influenza A virus infection.
Gocník M; Fislová T; Mucha V; Sládková T; Russ G; Kostolanský F; Varečková E
J Gen Virol; 2008 Apr; 89(Pt 4):958-967. PubMed ID: 18343837
[TBL] [Abstract][Full Text] [Related]
5. Heterosubtypic protection against influenza A induced by adenylate cyclase toxoids delivering conserved HA2 subunit of hemagglutinin.
Staneková Z; Adkins I; Kosová M; Janulíková J; Sebo P; Varečková E
Antiviral Res; 2013 Jan; 97(1):24-35. PubMed ID: 23036818
[TBL] [Abstract][Full Text] [Related]
6. Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin.
Bright RA; Carter DM; Daniluk S; Toapanta FR; Ahmad A; Gavrilov V; Massare M; Pushko P; Mytle N; Rowe T; Smith G; Ross TM
Vaccine; 2007 May; 25(19):3871-8. PubMed ID: 17337102
[TBL] [Abstract][Full Text] [Related]
7. Recombinant adenovirus encoding the HA gene from swine H3N2 influenza virus partially protects mice from challenge with heterologous virus: A/HK/1/68 (H3N2).
Tang M; Harp JA; Wesley RD
Arch Virol; 2002 Nov; 147(11):2125-41. PubMed ID: 12417948
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibodies to glycopolypeptides HA1 and HA2 of influenza virus haemagglutinin.
Russ G; Poláková K; Kostolanský F; Styk B; Vancíková M
Acta Virol; 1987 Sep; 31(5):374-86. PubMed ID: 2891276
[TBL] [Abstract][Full Text] [Related]
9. Immunization with influenza A NP-expressing vaccinia virus recombinant protects mice against experimental infection with human and avian influenza viruses.
Altstein AD; Gitelman AK; Smirnov YA; Piskareva LM; Zakharova LG; Pashvykina GV; Shmarov MM; Zhirnov OP; Varich NP; Ilyinskii PO; Shneider AM
Arch Virol; 2006 May; 151(5):921-31. PubMed ID: 16292596
[TBL] [Abstract][Full Text] [Related]
10. Protection against avian influenza H9N2 virus challenge by immunization with hemagglutinin- or neuraminidase-expressing DNA in BALB/c mice.
Qiu M; Fang F; Chen Y; Wang H; Chen Q; Chang H; Wang F; Wang H; Zhang R; Chen Z
Biochem Biophys Res Commun; 2006 May; 343(4):1124-31. PubMed ID: 16580631
[TBL] [Abstract][Full Text] [Related]
11. Immunization against influenza A virus: comparison of conventional inactivated, live-attenuated and recombinant baculovirus produced purified hemagglutinin and neuraminidase vaccines in a murine model system.
Brett IC; Johansson BE
Virology; 2005 Sep; 339(2):273-80. PubMed ID: 15996702
[TBL] [Abstract][Full Text] [Related]
12. Sindbis virus vectors elicit hemagglutinin-specific humoral and cellular immune responses and offer a dose-sparing strategy for vaccination.
Miller A; Center RJ; Stambas J; Deliyannis G; Doherty PC; Howard JL; Turner SJ; Purcell DF
Vaccine; 2008 Oct; 26(44):5641-8. PubMed ID: 18761047
[TBL] [Abstract][Full Text] [Related]
13. Protection of mice against lethal infection with highly pathogenic H7N7 influenza A virus by using a recombinant low-pathogenicity vaccine strain.
de Wit E; Munster VJ; Spronken MI; Bestebroer TM; Baas C; Beyer WE; Rimmelzwaan GF; Osterhaus AD; Fouchier RA
J Virol; 2005 Oct; 79(19):12401-7. PubMed ID: 16160167
[TBL] [Abstract][Full Text] [Related]
14. Influenza hemagglutinin vaccine with poly(gamma-glutamic acid) nanoparticles enhances the protection against influenza virus infection through both humoral and cell-mediated immunity.
Okamoto S; Yoshii H; Akagi T; Akashi M; Ishikawa T; Okuno Y; Takahashi M; Yamanishi K; Mori Y
Vaccine; 2007 Nov; 25(49):8270-8. PubMed ID: 17977633
[TBL] [Abstract][Full Text] [Related]
15. Synthetic double-stranded RNA poly(I:C) combined with mucosal vaccine protects against influenza virus infection.
Ichinohe T; Watanabe I; Ito S; Fujii H; Moriyama M; Tamura S; Takahashi H; Sawa H; Chiba J; Kurata T; Sata T; Hasegawa H
J Virol; 2005 Mar; 79(5):2910-9. PubMed ID: 15709010
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of nasal immunization of influenza virus hemagglutinin with recombinant cholera toxin B subunit as a mucosal adjuvant in mice.
Isaka M; Zhao Y; Nobusawa E; Nakajima S; Nakajima K; Yasuda Y; Matsui H; Hasegawa T; Maeyama J; Morokuma K; Ohkuma K; Tochikubo K
Microbiol Immunol; 2008 Feb; 52(2):55-63. PubMed ID: 18380802
[TBL] [Abstract][Full Text] [Related]
17. Heterosubtypic protective immunity against influenza A virus induced by fusion peptide of the hemagglutinin in comparison to ectodomain of M2 protein.
Staneková Z; Király J; Stropkovská A; Mikušková T; Mucha V; Kostolanský F; Varečková E
Acta Virol; 2011; 55(1):61-7. PubMed ID: 21434706
[TBL] [Abstract][Full Text] [Related]
18. Human Monoclonal Antibody 81.39a Effectively Neutralizes Emerging Influenza A Viruses of Group 1 and 2 Hemagglutinins.
Marjuki H; Mishin VP; Chai N; Tan MW; Newton EM; Tegeris J; Erlandson K; Willis M; Jones J; Davis T; Stevens J; Gubareva LV
J Virol; 2016 Dec; 90(23):10446-10458. PubMed ID: 27630240
[TBL] [Abstract][Full Text] [Related]
19. Characterization of live influenza vaccine donor strain derived from cold-adaptation of X-31 virus.
Lee KH; Seo SU; Song JM; Lee CM; Kim HA; Seong BL
Vaccine; 2006 Mar; 24(11):1966-74. PubMed ID: 16343703
[TBL] [Abstract][Full Text] [Related]
20. Recombinant modified vaccinia virus Ankara-based vaccine induces protective immunity in mice against infection with influenza virus H5N1.
Kreijtz JH; Suezer Y; van Amerongen G; de Mutsert G; Schnierle BS; Wood JM; Kuiken T; Fouchier RA; Lower J; Osterhaus AD; Sutter G; Rimmelzwaan GF
J Infect Dis; 2007 Jun; 195(11):1598-606. PubMed ID: 17471429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]